Recent studies have suggested that dexmedetomidine alleviates sepsis-induced myocardial cellular injury by attenuating sepsis-induced HO-1 overexpression and increased iron concentration and reducing ferroptosis via enhancing GPX4 [17]. The gene discussed is GPX4; the disease is Sepsis.